Comparison
5p Partial Monosomy Syndrome C0010314 vs 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
Clinical comparison between 5P Partial Monosomy Syndrome and 2 Methylacetoacetyl Coa Thiolase Deficiency for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
A rare metabolic disorder affecting how the body breaks down certain amino acids. It can cause buildup of harmful acids. Treatment focuses on diet and managing metabolic crises.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
0-5
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
moderate
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
metabolic
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
metabolic
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 2-methylacetoacetyl-coa-thiolase-deficiency-C2930874 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874 | Discriminating power |
|---|---|---|---|
| Newborn cry | A high-pitched cry is a characteristic reported feature. | No characteristic cry is established by the supplied description. | High |
| Metabolic crisis | Not described as an episodic acid-buildup disorder. | May cause harmful acid accumulation and metabolic crises. | High |
| Development | Developmental delay and intellectual disability are described. | Neurodevelopment may be affected, but this is not established here. | Moderate |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Congenital features from birth
Supplied onset is at birth and the condition is classified as congenital and genetic.
High
Characteristic cry with developmental concerns
These features align with the supplied syndrome description.
Moderate
Suspected chromosomal deletion
The stated cause is deletion of chromosome 5, requiring clinician-directed genetic testing.
High
Choose 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874 when
Early-childhood metabolic illness
Supplied onset spans birth to age five and the category is metabolic.
Moderate
Suspected acid accumulation
The description specifically mentions buildup of harmful acids.
Moderate
Need for dietary crisis planning
Described management focuses on diet and treatment of metabolic crises.
High
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 2 Methylacetoacetyl Coa Thiolase Deficiency C2930874 | Interpretation |
|---|---|---|---|
| Chromosomal or genomic testing | May identify a chromosome 5 deletion when clinically indicated. | Not the primary test suggested by the metabolic description. | A genetic result supports, but does not replace, clinical interpretation. |
| Metabolic urine or blood studies | No characteristic acid-metabolite pattern is supplied. | May be used to investigate abnormal organic acids or related metabolites. | Abnormal results are findings, not a diagnosis by themselves. |
| Enzyme or gene testing | Not described as the defining test for this chromosomal condition. | May help confirm the suspected enzyme deficiency when selected by a specialist. | Exact methods and cutoffs are not established here. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- A severe chronic congenital course is described, but individual outcomes are not established.
- Factors
- Deletion characteristics, developmental findings, and available support may influence course.
2 Methylacetoacetyl Coa Thiolase Deficiency C2930874
- Outcome
- A moderate chronic metabolic condition is described, with risk during crises.
- Factors
- Crisis recognition, dietary management, and specialist follow-up are relevant, but effect sizes are unknown.
Time frame: Both are described as chronic; exact timelines are not supplied.
Prognosis should be interpreted by clinicians because mortality and outcome data are not provided.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Developmental delay and intellectual disability are described. Possible effects are not established by the supplied source. Severity and functional impact vary and need individual assessment. |
| Metabolic decompensation | Not identified as a typical complication in the source. Harmful acid buildup and crises are described risks. Triggers, laboratory thresholds, and emergency steps are not specified here. |
| Long-term support needs | Severe congenital course may require ongoing developmental support. Chronic metabolic management and crisis prevention may be needed. Neither prognosis nor support intensity can be quantified from these data. |
Patient education highlights
- HighDistinct causes
One is a chromosomal deletion; the other is a rare metabolic disorder. They are not interchangeable diagnoses.
- HighUrgent metabolic symptoms
For the metabolic disorder, worsening illness should prompt urgent clinician advice; exact warning signs are not listed here.
- MediumIndividualized care
Testing, diet, developmental support, and follow-up should be directed by qualified clinicians.